DLA Piper has advised AB MälarVerken on the deal.
IV Group has completed the acquisition of the Swedish-based Frohe Group. The company was established in 1991 and is today mainly operating in the Medical- & Industrial sector. The acquisition means IV Group is adding Medical to its portfolio as well as expanding geographically with manufacturing sites added both in Sweden and in Poland.
Frohe Group was founded 1991 and has from the beginning attracted interest from customers thanks to their innovative mind-set & technical skills within the injection moulding industry. The company’s products are mainly used in medical devices but also in the food processing industry as well as various industrial applications.
IV Group is a Norwegian group with operations in Asia and Europe. We develop and manufacture products in polymer materials for customers within medical technology, consumer products, automotive and other selected industrial sectors. We also manufacture tools for the injection moulding industry as well as machining services. Main owners of IV Group is Verdane Capital and IV Holding where Verdane Capital is the majority owner.
The DLA Piper team mainly consisted of Petter Kjöllerström (Picture), together with Anders Svensson and Sara Latrach.
Law Firms: DLA Piper;
Clients: AB MälarVerken;